DNLI Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $20.00

Capitalizzazione di Mercato (MRQ) $3.20B

P/E -6.8

EPS $-2.97

Ricavi $0

ROE -50.2%

Intervallo 52 sett. $14–$27

DNLI Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$0

2016-12-31 → 2025-12-31

EPS$-2.97

2018-12-31 → 2025-12-31

Flusso di cassa libero$-422M

2018-12-31 → 2025-12-31

Margine netto·

2018-12-31 → 2023-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	DNLI	media 5 anni	Mediana dei peer	Verdetto
P/E	-6.8media 5 anni ≈-12.6	≈-12.6	·	·
P/B (MRQ)	3.8media 5 anni ≈3.4	≈3.4	4.2	Più costoso
Prezzo / FCF (TTM)	-7.3media 5 anni ≈-12.3	≈-12.3	·	·
Prezzo / Flusso di cassa (TTM)	-7.4media 5 anni ≈-12.9	≈-12.9	·	·
Prezzo / Valore contabile tangibile (MRQ)	4.0media 5 anni ≈3.4	≈3.4	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	Tendenza 5 anni	DNLI	media 5 anni	Mediana dei peer	Verdetto
ROA		-40.7%media 5 anni ≈-25.5%	≈-25.5%	-7.4%	Debole
ROE		-50.2%media 5 anni ≈-32.3%	≈-32.3%	-8.3%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	DNLI	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		8.4media 5 anni ≈7.5	≈7.5	6.5	Liquidità elevata
Quick Ratio (MRQ)		7.9media 5 anni ≈7.2	≈7.2	5.0	Liquidità elevata

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	Tendenza 5 anni	DNLI	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)		204.7%media 5 anni ≈80.7%	≈80.7%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)		-0.51%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	DNLI	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-2.97media 5 anni ≈$-2.32	≈$-2.32	·	·
Revenue / Share (Ricavi / Azione)	$0.00media 5 anni ≈$0.73	≈$0.73	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-2.39media 5 anni ≈$-2.16	≈$-2.16	·	·
Cash / Share (Liquidità / Azione)	$1.31media 5 anni ≈$1.49	≈$1.49	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	DNLI	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.0media 5 anni ≈0.1	≈0.1	0.2	Debole
Revenue / Employee (Ricavi / Dipendente)		≈$0.00	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 0.52%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-0.68	$-0.67	-1.5%
31 Marzo 2026		$-0.69	$-0.74	6.8%
31 Dicembre 2025		$-0.73	$-0.76	3.8%
30 Settembre 2025		$-0.74	$-0.77	3.5%
30 Giugno 2025		$-0.72	$-0.73	1.9%
31 Marzo 2025		$-0.78	$-0.70	-11.4%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 13

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$0	$0	$331M	$108M	$49M	$336M	$27M	$129M	$0
R&D Expense	$419M	$396M	$424M	$359M	$265M	$213M	$193M	$143M	$74M
SG&A Expense	$137M	$105M	$103M	$90M	$79M	$60M	$46M	$32M	$16M
Operating Expenses	$555M	$502M	$527M	$449M	$344M	$273M	$240M	$176M	$90M
Operating Income	$-555M	$-487M	$-197M	$-341M	$-296M	$63M	$-213M	$-46M	$-90M
Other Non-op	·	·	$52M	$15M	$5M	$9M	$15M	$10M	$2M
Income Tax	$102.0K	$68.0K	$30.0K	$21.0K	$-575.0K	$823.0K	$-351.0K	$0	$0
Net Income	$-513M	$-423M	$-145M	$-326M	$-291M	$71M	$-198M	$-36M	$-88M
EPS (Basic)	$-2.97	$-2.57	$-1.06	$-2.60	$-2.39	$0.65	$-2.07	$-0.39	·
EPS (Diluted)	$-2.97	$-2.57	$-1.06	$-2.60	$-2.39	$0.63	$-2.07	$-0.39	·
Shares (Basic)	172,649,097	164,473,772	137,370,897	125,530,703	121,524,795	108,974,137	95,608,208	92,621,991	·
Shares (Diluted)	172,649,097	164,473,772	137,370,897	125,530,703	121,524,795	112,703,108	95,608,208	92,621,991	·
EBITDA	$-544M	$-480M	$-180M	$-330M	$-287M	$71M	$-205M	$-39M	·

Stato Patrimoniale 25

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$205M	$175M	$127M	$218M	$293M	$507M	$79M	$77M	$218M
Short-term Investments	$663M	$657M	$907M	$1.12B	$572M	$963M	$336M	$387M	$188M
Receivables	$0	·	·	·	·	$9M	·	·	·
Inventory	$0	·	·	·	·	·	·	·	·
Prepaid Expense	$33M	$32M	$30M	$36M	$31M	$20M	$15M	$17M	$3M
Current Assets	$901M	$864M	$1.06B	$1.37B	$897M	$1.50B	$430M	$481M	$410M
PP&E (Net)	$52M	$55M	$46M	$44M	$39M	$41M	$47M	$25M	$15M
PP&E (Gross)	$115M	$107M	$92M	$81M	$68M	$62M	$59M	$37M	$20M
Accum. Depreciation	$63M	$52M	$46M	$37M	$29M	$21M	$12M	$12M	$5M
Intangibles	$0	·	·	·	·	·	·	·	·
Other Non-current Assets	$26M	$25M	$18M	$13M	$12M	$2M	$3M	$8M	$1M
Total Assets	$1.14B	$1.37B	$1.15B	$1.46B	$1.40B	$1.60B	$553M	$662M	$487M
Accounts Payable	$505.0K	$11M	$9M	$3M	$5M	$1M	$3M	$2M	$3M
Accrued Liabilities	$98M	$91M	$68M	$67M	·	$8M	$7M	$9M	$5M
Current Liabilities	$98M	$102M	$78M	$364M	$378M	$72M	$45M	$33M	$14M
Capital Leases	$27M	$37M	$45M	$53M	$59M	$64M	$69M	·	·
Other Non-current Liabilities	·	·	$0	$379.0K	$379.0K	$701.0K	$379.0K	$471.0K	$467.0K
Total Liabilities	$131M	$144M	$123M	$418M	$442M	$454M	$158M	$115M	$21M
Common Stock	·	·	$2M	$2M	$2M	$2M	$1M	$1M	$1M
Paid-in Capital	$3.06B	$2.76B	$2.14B	$2.02B	$1.61B	$1.50B	$819M	$774M	$657M
Retained Earnings	$-2.05B	$-1.54B	$-1.12B	$-971M	$-645M	$-354M	$-426M	$-228M	$-192M
AOCI	$682.0K	$2M	$643.0K	$-7M	$-2M	$-245.0K	$350.0K	$-649.0K	$-368.0K
Stockholders' Equity	$1.01B	$1.23B	$1.03B	$1.04B	$962M	$1.15B	$395M	$547M	$466M
Liabilities + Equity	$1.14B	$1.37B	$1.15B	$1.46B	$1.40B	$1.60B	$553M	$662M	$487M
Shares Outstanding	156,182,177	144,220,986	138,385,498	135,965,918	122,283,305	120,531,333	96,189,935	94,662,435	87,480,362

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$11M	$8M	$17M	$10M	$9M	$9M	$8M	$7M	$3M
Stock-based Comp	$100M	$103M	$108M	$100M	$85M	$50M	$38M	$19M	$4M
Deferred Tax	$0	$0	$0	$0	$0	$0	$-351.0K	·	·
Other Non-cash	$-11M	$-36M	$-338M	$-29M	$-15M	$286M	$-331.0K	$60M	·
Operating Cash Flow	$-413M	$-348M	$-358M	$-245M	$-211M	$416M	$-152M	$50M	$-77M
CapEx	$10M	$16M	$13M	$18M	$8M	$3M	$18M	$3M	$3M
Investing Cash Flow	$255M	$-89M	$249M	$-141M	$-22M	$-623M	$148M	$-287M	$-41M
Stock Issued	·	$0	$0	$296M	$0	$194M	$0	$0	$266M
Net Stock Activity	·	$0	$0	$296M	$0	$194M	$0	$0	·
Financing Cash Flow	$189M	$484M	$18M	$311M	$19M	$635M	$6M	$97M	$296M
Net Change in Cash	$32M	$48M	$-91M	$-75M	$-214M	$428M	·	·	·
Taxes Paid	$46.0K	$0	$3.0K	$47.0K	$210.0K	$0	·	·	·
Free Cash Flow	$-422M	$-364M	$-371M	$-263M	$-220M	$413M	$-169M	$47M	·

Redditività 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	·	·	-59.5%	-314.2%	-607.8%	18.7%	-799.1%	-35.9%	·
Net Margin	·	·	-43.9%	-300.6%	-597.1%	21.2%	-740.7%	-28.1%	·
EBITDA Margin	·	·	-54.4%	-304.6%	-590.1%	21.2%	-769.1%	-30.2%	·
ROA	-40.7%	-33.5%	-11.1%	-22.8%	-19.3%	6.6%	-32.5%	-6.3%	·
ROE	-50.2%	-33.2%	-13.5%	-35.2%	-29.4%	7.0%	-47.4%	-7.2%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio		9.2	8.5	13.6	3.8	2.4	20.9	9.5	14.7	·
Quick Ratio		8.8	8.1	13.3	3.7	2.3	20.5	9.2	14.2	·

Efficienza 1

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover		0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.2	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$6.49	$8.53	$7.45	$7.67	$7.87	$9.55	$4.11	$5.78	·
Revenue / Share	$0.00	$0.00	$2.41	$0.86	$0.40	$2.98	·	·	·
Cash Flow / Share	$-2.39	$-2.11	$-2.61	$-1.95	$-1.74	$3.69	·	·	·
Cash / Share	$1.31	$1.21	$0.92	$1.60	$2.40	$4.21	$0.83	$0.81	·
EPS (TTM)	$-2.97	$-2.57	$-1.06	$-2.60	$-2.39	$0.63	$-2.07	$-0.39	·

Tassi di Crescita 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY		·	·	204.7%	122.9%	-85.5%	·	·	·	·
Revenue CAGR 3Y		·	·	-0.51%	·	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$0	$0	$331M	$108M	$49M	$336M	$27M	$129M	$0
Net Income TTM	$-513M	$-423M	$-145M	$-326M	$-291M	$71M	$-198M	$-36M	$-88M
Market Cap	$2.58B	$2.94B	$2.97B	$3.78B	$5.45B	$10.10B	$1.68B	$1.96B	·
P/E	-5.6	-7.9	-20.2	-10.7	-18.7	133.0	-8.4	-53.0	·
P/S	·	·	9.0	34.9	112.1	30.1	62.8	15.1	·
P/B	2.5	2.4	2.9	3.6	5.7	8.8	4.2	3.6	·
P / Tangible Book	2.5	2.4	2.9	3.6	5.7	8.8	·	·	·
P / Cash Flow	-6.2	-8.5	-8.3	-15.5	-25.8	24.3	-11.1	39.0	·
P / FCF	-6.1	-8.1	-8.0	-14.4	-24.8	24.4	-9.9	41.9	·
Earnings Yield	-18.0%	-12.6%	-4.9%	-9.3%	-5.4%	0.75%	-11.9%	-1.9%	·

Conto Economico 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue	$4M	·	·	·	$0	·	$0	$0	$0	$0	$1M	$294M	$35M	$4M	$52M	$42M
Cost of Revenue	$93.0K	·	·	·	$0	·	·	·	·	·	·	·	·	·	·	·
R&D Expense	$97M	$104M	$98M	$102M	$103M	$116M	$100M	$98M	$91M	$107M	$90M	$98M	$129M	$88M	$93M	$86M
SG&A Expense	$36M	$34M	$39M	$35M	$32M	$29M	$30M	$25M	$25M	$25M	$25M	$26M	$27M	$23M	$21M	$23M
Operating Expenses	$134M	$137M	$137M	$137M	$135M	$146M	$130M	$123M	$117M	$132M	$115M	$124M	$156M	$111M	$114M	$109M
Operating Income	$-131M	$-137M	$-137M	$-137M	$-135M	$-146M	$-130M	$-123M	$-117M	$-118M	$-114M	$170M	$-121M	$-107M	$-61M	$-66M
Other Non-op	·	·	·	·	·	·	·	·	·	·	$14M	$13M	$11M	$4M	$3M	$1M
Income Tax	·	·	·	·	·	·	·	·	·	·	$0	$0	·	$0	$27.0K	·
Net Income	$-128M	$-128M	$-129M	$-127M	$-124M	$-133M	$-115M	$-107M	$-99M	$-102M	$-99M	$183M	$-110M	$-103M	$-59M	$-65M
EPS (Basic)	$-0.68	$-0.69	$-0.73	$-0.74	$-0.72	$-0.78	$-0.67	$-0.63	$-0.59	$-0.68	$-0.72	$1.34	$-0.80	$-0.84	$-0.48	$-0.53
EPS (Diluted)	$-0.68	$-0.69	$-0.73	$-0.74	$-0.72	$-0.78	$-0.67	$-0.63	$-0.59	$-0.68	$-0.72	$1.30	$-0.80	$-0.84	$-0.48	$-0.53
Shares (Basic)	187,314,501	186,636,978	·	172,421,492	171,449,847	171,222,030	·	169,456,988	168,831,329	149,404,188	137,644,534	137,047,227	136,524,528	123,473,390	123,008,558	122,673,935
Shares (Diluted)	187,314,501	186,636,978	·	172,421,492	171,449,847	171,222,030	·	169,456,988	168,831,329	149,404,188	137,644,534	140,930,625	136,524,528	123,473,390	123,008,558	122,673,935
EBITDA	$-131M	$-135M	·	$-137M	$-135M	$-143M	·	$-123M	$-117M	$-116M	$-114M	$170M	$-111M	$-107M	$-61M	$-64M

Stato Patrimoniale 25

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$202M	$388M	$205M	$91M	$141M	$57M	$175M	$91M	$75M	$61M	$148M	$132M	$68M	$119M	$155M	$105M
Short-term Investments	$509M	$600M	$663M	$757M	$758M	$761M	$657M	$746M	$821M	$876M	$961M	$1.06B	$1.22B	$987M	$914M	$853M
Receivables	$4M	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Inventory	$4M	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Prepaid Expense	$35M	$35M	$33M	$34M	$36M	$61M	$32M	$32M	$32M	$37M	$34M	$33M	$37M	$32M	$46M	$31M
Current Assets	$754M	$1.02B	$901M	$883M	$935M	$879M	$864M	$869M	$928M	$974M	$1.14B	$1.22B	$1.33B	$1.14B	$1.11B	$988M
PP&E (Net)	$50M	$52M	$52M	$54M	$59M	$58M	$55M	$51M	$48M	$47M	$48M	$40M	$42M	$42M	$39M	$38M
PP&E (Gross)	·	·	$115M	·	·	·	$107M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$63M	·	·	·	$52M	·	·	·	·	·	·	·	·	·
Intangibles	$35M	$36M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$26M	$26M	$26M	$25M	$23M	$27M	$25M	$26M	$51M	$45M	$11M	$14M	$14M	$16M	$15M	$14M
Total Assets	$1.16B	$1.27B	$1.14B	$1.06B	$1.17B	$1.27B	$1.37B	$1.45B	$1.50B	$1.58B	$1.24B	$1.31B	$1.41B	$1.23B	$1.29B	$1.32B
Accounts Payable	$12M	$40M	$3M	$7M	$11M	$8M	$11M	$10M	$14M	$12M	·	·	·	$8M	$7M	$3M
Accrued Liabilities	$78M	$70M	$95M	$5M	$7M	$7M	$91M	$5M	$6M	$6M	·	·	·	·	·	·
Current Liabilities	$90M	$110M	$98M	$90M	$91M	$92M	$102M	$87M	$75M	$83M	$71M	$69M	$391M	$361M	$348M	$341M
Capital Leases	$22M	$25M	$27M	$30M	$32M	$34M	$37M	$39M	$41M	$43M	$47M	$49M	$51M	$55M	$56M	$57M
Other Non-current Liabilities	·	·	·	·	·	·	·	·	·	·	$379.0K	$379.0K	$379.0K	$379.0K	$379.0K	$379.0K
Total Liabilities	$323M	$340M	$131M	$129M	$139M	$149M	$144M	$136M	$116M	$126M	$118M	$119M	$443M	$416M	$408M	$403M
Common Stock	·	·	·	·	·	·	·	·	·	·	$2M	$2M	$2M	$2M	$2M	$2M
Paid-in Capital	$3.14B	$3.10B	$3.06B	$2.85B	$2.82B	$2.79B	$2.76B	$2.74B	$2.70B	$2.67B	$2.11B	$2.08B	$2.05B	$1.69B	$1.66B	$1.64B
Retained Earnings	$-2.31B	$-2.18B	$-2.05B	$-1.92B	$-1.80B	$-1.67B	$-1.54B	$-1.42B	$-1.32B	$-1.22B	$-997M	$-897M	$-1.08B	$-872M	$-769M	$-710M
AOCI	$-2M	$-682.0K	$682.0K	$1M	$939.0K	$2M	$2M	$6M	$-3M	$-1M	$-651.0K	$-1M	$-3M	$-12M	$-12M	$-9M
Stockholders' Equity	$835M	$926M	$1.01B	$926M	$1.03B	$1.12B	$1.23B	$1.32B	$1.39B	$1.46B	$1.12B	$1.19B	$967M	$811M	$884M	$918M
Liabilities + Equity	$1.16B	$1.27B	$1.14B	$1.06B	$1.17B	$1.27B	$1.37B	$1.45B	$1.50B	$1.58B	$1.24B	$1.31B	$1.41B	$1.23B	$1.29B	$1.32B
Shares Outstanding	159,755,526	158,656,318	156,182,177	146,625,722	145,685,442	145,251,258	144,220,986	143,840,029	143,123,582	142,512,856	138,051,798	137,362,688	136,741,627	123,796,438	123,157,278	122,857,908

Flusso di cassa 13

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
D&A	$4M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$10M	$2M	$2M	$2M
Stock-based Comp	$23M	$23M	$24M	$25M	$25M	$25M	$25M	$25M	$25M	$28M	$27M	$27M	$28M	$25M	$24M	$26M
Amort. of Intangibles	$750.0K	·	·	·	$0	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	$-29M	·	·	·	$-26M	·	·	·	$-42M	·	·	$13M	·	·	$-35M
Operating Cash Flow	$-97M	$-131M	$-99M	$-107M	$-75M	$-131M	$-84M	$-59M	$-91M	$-114M	$-87M	$-113M	$-59M	$-57M	$-43M	$-72M
CapEx	$805.0K	$2M	$2M	$-1M	$4M	$5M	$5M	$4M	$5M	$2M	$2M	$6M	$3M	$6M	$3M	$4M
Investing Cash Flow	$-104M	$94M	$21M	$58M	$158M	$19M	$172M	$94M	$99M	$-453M	$101M	$168M	$-93M	$15M	$89M	$-118M
Stock Issued	$0	$12M	·	$0	$0	$0	·	$0	$0	$499M	$0	$0	$0	·	·	·
Net Stock Activity	·	$12M	·	·	·	$0	·	·	·	$499M	·	·	·	·	·	·
Financing Cash Flow	$15M	$219M	$192M	$-778.0K	$2M	$-4M	$-4M	$-19M	$7M	$500M	$2M	$9M	$2M	$5M	$4M	$1M
Net Change in Cash	$-186M	$182M	$114M	$-50M	$84M	$-116M	$84M	$16M	$14M	$-67M	$16M	$64M	$-150M	$-36M	$50M	$-189M
Taxes Paid	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0	$4.0K	$0	$0	$0
Free Cash Flow	·	$-134M	·	·	·	$-137M	·	·	·	$-116M	·	·	$-62M	·	·	$-76M

Redditività 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Operating Margin	-3622.1%	·	·	·	·	·	·	·	·	·	-8981.4%	58.0%	-343.8%	-3020.1%	-117.0%	-157.8%
Net Margin	-3539.2%	·	·	·	·	·	·	·	·	·	-7841.6%	62.4%	-312.4%	-2902.5%	-112.0%	-154.8%
EBITDA Margin	-3622.1%	·	·	·	·	·	·	·	·	·	-8981.4%	58.0%	-315.2%	-3020.1%	-117.0%	-152.9%
ROA	-11.0%	-10.1%	·	-10.1%	-9.3%	-9.3%	·	-8.0%	-7.0%	-6.8%	-8.1%	14.1%	-8.0%	-7.7%	-4.2%	-4.5%
ROE	-13.7%	-12.5%	·	-11.3%	-10.3%	-10.3%	·	-8.8%	-7.7%	-8.4%	-10.3%	17.7%	-11.7%	-11.3%	-6.0%	-6.5%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio		8.4	9.3	·	9.8	10.3	9.6	·	10.0	12.5	11.8	16.1	17.6	3.4	3.2	3.2	2.9
Quick Ratio		7.9	9.0	·	9.4	9.9	8.9	·	9.6	12.0	11.3	15.6	17.2	3.3	3.1	3.1	2.8

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Asset Turnover	0.0	·	·	·	·	·	·	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
Inventory Turnover	0.0	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Receivables Turnover	0.4	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	$5.23	$5.84	·	$6.32	$7.05	$7.73	·	$9.17	$9.69	$10.21	$8.10	$8.64	$7.07	$6.55	$7.18	$7.47
Revenue / Share	$0.02	·	·	·	·	·	·	$0.00	$0.00	$0.00	$0.01	$2.09	$0.26	$0.03	$0.43	$0.34
Cash Flow / Share	·	$-0.70	·	·	·	$-0.77	·	·	·	$-0.76	·	·	$-0.43	·	·	$-0.59
Cash / Share	$1.26	$2.44	·	$0.62	$0.97	$0.39	·	$0.63	$0.52	$0.42	$1.07	$0.96	$0.50	$0.96	$1.26	$0.85
EPS (TTM)	$-2.84	$-2.88	·	$-2.91	$-2.80	$-2.67	·	$-2.74	$-2.83	$-0.94	$-0.97	$-1.09	$-2.87	$-2.47	$-2.32	$-2.34

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Revenue TTM	·	·	·	·	·	$0	·	$0	$1M	$295M	$341M	$343M	$101M	$111M	$112M	$83M
Net Income TTM	$-511M	$-508M	·	$-499M	$-479M	$-454M	·	$-427M	$-420M	$-137M	$-124M	$-128M	$-371M	$-303M	$-284M	$-286M
Market Cap	$4.11B	$3.05B	·	$2.13B	$2.04B	$1.97B	·	$4.19B	$3.32B	$2.92B	$2.85B	$4.05B	$3.15B	$3.80B	$3.62B	$3.95B
P/E	-9.1	-6.7	·	-5.0	-5.0	-5.1	·	-10.6	-8.2	-21.8	-21.3	-27.1	-8.0	-12.4	-12.7	-13.7
P/S	·	·	·	·	·	·	·	·	2623.0	9.9	8.4	11.8	31.1	34.3	32.2	47.7
P/B	4.9	3.3	·	2.3	2.0	1.8	·	3.2	2.4	2.0	2.5	3.4	3.3	4.7	4.1	4.3
P / Tangible Book	5.1	3.4	·	2.3	2.0	1.8	·	3.2	2.4	2.0	2.5	3.4	3.3	4.7	4.1	4.3
P / Cash Flow	·	-23.2	·	·	·	-15.0	·	·	·	-25.7	·	·	-53.6	·	·	-54.8
Earnings Yield	-11.0%	-15.0%	·	-20.0%	-20.0%	-19.6%	·	-9.4%	-12.2%	-4.6%	-4.7%	-3.7%	-12.5%	-8.1%	-7.9%	-7.3%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$0	$0	$331M	$108M	$49M
Margine Operativo %	·	·	-59.5%	-314.2%	-607.8%
Utile netto	$-513M	$-423M	$-145M	$-326M	$-291M
EPS Diluito	$-2.97	$-2.57	$-1.06	$-2.60	$-2.39

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	9.2	8.5	13.6	3.8	2.4
Quick Ratio	8.8	8.1	13.3	3.7	2.3

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-422M	$-364M	$-371M	$-263M	$-220M

Proprietari istituzionali (13F) 316 filer · $3.8B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 316

Valore detenuto $3.8B

Nuove posizioni 55

Posizioni chiuse 27

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
55 (-11 vs trimestre precedente)	27 (+1 vs trimestre precedente)	123 (+18 vs trimestre precedente)	68 (+11 vs trimestre precedente)	+6.1M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$360.759.342	14.026.413	9,60%	Azioni
BAILLIE GIFFORD & CO	$307.617.116	11.960.230	8,18%	Azioni
VANGUARD GROUP INC	$215.585.764	13.057.890	5,74%	Azioni
STATE STREET CORP	$181.308.099	7.049.304	4,82%	Azioni
Temasek Holdings (Private) Ltd	$180.373.691	7.012.974	4,80%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$166.589.906	6.477.057	4,43%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$161.411.750	6.275.729	4,29%	Azioni
FMR LLC	$116.661.699	4.535.836	3,10%	Azioni
GOLDMAN SACHS GROUP INC	$106.889.625	4.155.895	2,84%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$102.212.911	3.973.342	2,72%	Azioni
Holocene Advisors, LP	$100.442.387	3.905.225	2,67%	Azioni
BAKER BROS. ADVISORS LP	$96.047.122	3.734.336	2,56%	Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$85.100.430	4.432.314	2,26%	Azioni
UBS Group AG	$80.261.627	3.120.592	2,14%	Azioni
DIMENSIONAL FUND ADVISORS LP	$73.575.277	2.860.604	1,96%	Azioni
NORGES BANK	$72.652.467	2.824.746	1,93%	Azioni
Pictet Asset Management Holding SA	$71.894.854	2.791.206	1,91%	Azioni
Capital Research Global Investors	$65.992.813	2.565.817	1,76%	Azioni
Fisher Asset Management, LLC	$62.092.245	2.414.162	1,65%	Azioni
ALLIANCEBERNSTEIN L.P.	$57.308.294	2.984.807	1,52%	Azioni
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$56.797.000	2.208.263	1,51%	Azioni
Casdin Capital, LLC	$52.597.400	2.045.000	1,40%	Azioni
Crestline Management, L.P.	$49.144.027	1.910.732	1,31%	Azioni
PRINCIPAL FINANCIAL GROUP INC	$36.524.535	1.420.083	0,97%	Azioni
Foresite Capital Management VI LLC	$35.924.950	1.396.771	0,96%	Azioni
Siren, L.L.C.	$35.918.314	1.396.513	0,96%	Azioni
NORTHERN TRUST CORP	$35.744.756	1.389.765	0,95%	Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$34.863.820	1.355.514	0,93%	Azioni
Aberdeen Group plc	$34.605.771	1.345.481	0,92%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$32.020.243	1.244.955	0,85%	Azioni
BANK OF AMERICA CORP /DE/	$31.660.215	1.230.957	0,84%	Azioni
Artisan Partners Limited Partnership	$31.494.063	1.224.497	0,84%	Azioni
Candriam S.C.A.	$30.574.423	1.189.886	0,81%	Azioni
MILLENNIUM MANAGEMENT LLC	$28.954.239	1.125.748	0,77%	Azioni
ADAR1 Capital Management, LLC	$26.467.938	1.029.080	0,70%	Azioni
VANGUARD FIDUCIARY TRUST CO	$25.511.771	991.904	0,68%	Azioni
MORGAN STANLEY	$24.718.235	961.050	0,66%	Azioni
Bank of New York Mellon Corp	$20.583.293	800.283	0,55%	Azioni
DAFNA Capital Management LLC	$19.007.440	739.014	0,51%	Azioni
AMERICAN CENTURY COMPANIES INC	$18.326.346	712.526	0,49%	Azioni
Cercano Management LLC	$16.075.000	625.000	0,43%	Azioni
Nuveen, LLC	$15.662.631	608.967	0,42%	Azioni
Ensign Peak Advisors, Inc	$14.986.247	582.669	0,40%	Azioni
MARSHALL WACE, LLP	$14.141.627	549.830	0,38%	Azioni
SEGALL BRYANT & HAMILL, LLC	$13.361.103	519.483	0,36%	Azioni
CITIGROUP INC	$12.532.790	487.278	0,33%	Azioni
CITADEL ADVISORS LLC	$11.723.176	455.800	0,31%	Opzione Put
Balyasny Asset Management L.P.	$11.131.616	432.800	0,30%	Opzione Call
Defilade Capital Management, L.P.	$10.078.794	391.866	0,27%	Azioni
AQR CAPITAL MANAGEMENT LLC	$9.991.416	388.469	0,27%	Azioni

Mostra tutti i 316 proprietari istituzionali →

Insider aziendali 18 insider · 4 dirigenti · 13 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Ryan J. Watts	President and CEO	12 Agosto 2026 G	2.120.384	1	$-580.767
Peter Scott Chin	Chief Medical Officer	04 Settembre 2026 S	204.538	1	$-36.868
Alexander O. Schuth	COFO and Secretary	01 Settembre 2026 S	278.995	3	$-420.604
Carole Ho	Chief Medical Officer	13 Agosto 2025 S	216.585	0	$0
Nancy Thornberry	Direttore	02 Settembre 2026 S	19.686	2	$-261.928
Timothy Van Hauwermeiren	Direttore	03 Giugno 2026 A	17.040	0	$0
Jennifer E. Cook	Direttore	03 Giugno 2026 A	32.483	0	$0
Steve E. Krognes	Direttore	03 Giugno 2026 A	38.202	0	$0
David P Schenkein	Direttore	03 Giugno 2026 A	21.665	0	$0
Peter S Klein	Direttore	03 Giugno 2026 A	33.941	0	$0
Jay T Flatley	Direttore	03 Giugno 2026 A	22.628	0	$0
Marc Tessier-Lavigne	Direttore	03 Giugno 2025 A	1.886.576	0	$0
Vicki L Sato	Direttore	02 Gennaio 2025 S	107.976	0	$0
Erik Harris	Direttore	31 Maggio 2024 A	17.052	0	$0
Douglas G. Cole	Direttore	01 Giugno 2023 A	26.564	0	$0
Robert Nelsen	Direttore	02 Giugno 2021 A	12.432	0	$0
FMR LLC	·	09 Aprile 2018	·	0	$0
FIL Ltd	·	12 Dicembre 2017 C	1.379	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 40 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IBRN · iShares Trust	3,34%	11.666 SH	11 Settembre 2026	Giornaliero
BBP · ETFis Series Trust I	1,46%	62.658 NS	31 Luglio 2026	N-PORT
PTH · Invesco Exchange-Traded Fund Trust	0,83%	148.066 SH	01 Ottobre 2026	Giornaliero
LABU · Direxion Shares ETF Trust	0,55%	117.771 NS	31 Luglio 2026	N-PORT
IBB · iShares Trust	0,24%	1.135.594 SH	11 Settembre 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,23%	121.790 SH	19 Agosto 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,22%	11.322 SH	01 Ottobre 2026	Giornaliero
PWS · Pacer Funds Trust	0,15%	1.609 NS	31 Luglio 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0,15%	5.790 NS	31 Luglio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,15%	189.888 SH	01 Ottobre 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,12%	36.586 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,11%	846.335 SH	19 Agosto 2026	Giornaliero
RSSL · Global X Funds	0,11%	70.425 NS	31 Luglio 2026	N-PORT
IWM · iShares Trust	0,10%	3.761.614 SH	11 Settembre 2026	Giornaliero
VBK · VANGUARD INDEX FUNDS	0,09%	1.784.440 SH	19 Agosto 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,07%	456.915 NS	31 Luglio 2026	N-PORT
ESML · iShares Trust	0,06%	76.805 SH	11 Settembre 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,05%	405.796 SH	19 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,04%	64.057 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,04%	1.731.356 SH	19 Agosto 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,04%	3.091.727 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,03%	7.770 SH	11 Settembre 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,01%	238.844 NS	31 Luglio 2026	N-PORT
IWO · iShares Trust	0,01%	74.347 SH	11 Settembre 2026	Giornaliero
TILT · FlexShares Trust	0,01%	10.428 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,01%	14.634 NS	31 Luglio 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	8.139 SH	19 Agosto 2026	Giornaliero
ESGV · VANGUARD WORLD FUND	0,01%	32.379 SH	19 Agosto 2026	Giornaliero
DFAU · Dimensional ETF Trust	0,01%	38.627 NS	31 Luglio 2026	N-PORT
DXUV · Dimensional ETF Trust	0,01%	1.615 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	208.727 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	41.910 SH	10 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,00%	39.869 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	4.289.786 SH	19 Agosto 2026	Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,00%	117.791 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	11.822 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	1.308.489 SH	11 Settembre 2026	Giornaliero
ISCB · iShares Trust	·	6.080 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	29.811 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	257.359 SH	11 Settembre 2026	Giornaliero

DNLI Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 26 analisti COMPRA

Target mediano $35.00 +75,0%

11 42,3% Acquisto forte

13 50,0% Compra

2 7,7% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

16 analisti · 2026-10-02

Target medio $36.06 +80,3%

← Sotto tutti i target Prezzo attuale $20.00

Basso$27.00 Media$36.06 Alto$42.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
DNLI	$2.58B	-5.6	204.7%	·	-50.2%	·
CELC	$4.81B	-26.3	·	·	-244.3%	·
PBLS	·	·	·	·	·	·
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	·
ACAD	$4.55B	11.6	11.9%	36.5%	38.1%	·
ARQT	$3.58B	-223.4	91.3%	-4.3%	-9.8%	·
RCUS	$2.99B	-7.2	-4.3%	-142.9%	-59.8%	·
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	·
DYN	$3.23B	-5.6	·	·	-57.8%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·

Ultime notizie Notizie recenti che menzionano questa società

23

What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names Yahoo Finance · 3 mesi, 2 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

DNLI Denali Therapeutics Inc. - Common Stock